ISR Articles

  1. Small & Emerging Outsourced Manufacturing Activities

    To better understand the outsourcing practices used by respondents’ companies, ISR asked research participants to provide an estimate for various manufacturing activities.

  2. Small And Emerging Biopharma Companies Outsourcing Practices

    There is no question that the drug development services industry is complex, dynamic, and continuously evolving. While every sponsor company is different, all can benefit from keeping a pulse on current outsourcing practices and the activities being outsourced. Over the past year, ISR conducted several research activities with the aim of better understanding the needs of small and emerging biopharma companies and how they differ from the larger industry players. This article highlights the results of this survey.

  3. Old Dog, New Tricks: How Pharma Is Innovating With Existing Technologies

    Innovation in clinical technologies sometimes comes in the shape of disruptive new technologies or as a series of incremental changes and improvements. Find out how new data is revealing positive changes and existing tech solutions are now being used in new ways.

  4. Improving Manufacturing Outsourcing Relationships

    In Q4, 2018, ISR asked 100 sponsors who outsource manufacturing about several different scenarios that could potentially improve outsourcing relationships. The data below show how each of the scenarios panned out. A key common element across the most likely scenarios—communication. 

  5. Why Is It So Hard To Select A CMO?

    What can be done to alleviate some of the challenges in CMO selection? Learn the unexpected findings from the Industry Standard Research Outsourcing Models survey, from the perspective of a market researcher.